Dompé Farmaceutici

Dompé is an innovative Italian biopharmaceutical company. Dompé also has branches in the United States (Boston and San Francisco) and Europe, including Barcelona, Berlin, Paris, and Tirana.Dompé provides products to over 10,000 pharmacies in Italy and is committed to the development and distribution of ethical drugs and self-medication products, adjuvants, medical devices, cosmetics, as well as vitamins, mineral supplements, and personal hygiene products. Its therapeutic areas include cardiovascular, gastrointestinal, pediatrics, neurology, urology, ophthalmology, dentistry, and respiratory medicine. Dompé currently sells 50 million drug packages across approximately 40 countries worldwide. The biotechnology division embodies Dompé’s commitment to addressing unmet patient needs around the world. This division focuses specifically on rare diseases, such as in the field of ophthalmology, where the company has developed and marketed the first ophthalmic product based on rhNGF (a molecule discovered by Nobel laureate Rita Levi Montalcini).